Skip to main content
. 2020 Oct 9;2(12):2514–2520. doi: 10.1007/s42399-020-00569-6

Table 3.

Treatment and interventions

Initial oxygen treatment, %
  Oxygen supplementation via mask 25.9%
  Non-invasive ventilation 2.8%
  Invasive ventilation 46.9%
  No oxygen needed 24.4%
  Duration on invasive ventilation (days) (n = 63) 11.5 ± 10.0
Therapeutic interventions, %
  Antivirals 68.5%
  Antibiotics 97.2%
  Tocilizumab 33.5%
  Convalescent plasma 44%
  Anakinra 2%
  Plasma exchange 18.8%
  Renal replacement therapy 13.2%